130 related articles for article (PubMed ID: 10630784)
1. Pharmacokinetics of clomipramine in dogs following single-dose and repeated-dose oral administration.
King JN; Maurer MP; Altmann BO; Strehlau GA
Am J Vet Res; 2000 Jan; 61(1):80-5. PubMed ID: 10630784
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of clomipramine in dogs following single-dose intravenous and oral administration.
King JN; Maurer MP; Hotz RP; Fisch RD
Am J Vet Res; 2000 Jan; 61(1):74-9. PubMed ID: 10630783
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of clomipramine and desmethylclomipramine in dogs: parameter estimates following a single oral dose and 28 consecutive daily oral doses of clomipramine.
Hewson CJ; Conlon PD; Luescher UA; Ball RO
J Vet Pharmacol Ther; 1998 Jun; 21(3):214-22. PubMed ID: 9673963
[TBL] [Abstract][Full Text] [Related]
4. Regional distribution of clomipramine and desmethylclomipramine in rat brain and peripheral organs on chronic clomipramine administration.
Aitchison K; Datla K; Rooprai H; Fernando J; Dexter D
J Psychopharmacol; 2010 Aug; 24(8):1261-8. PubMed ID: 19553387
[TBL] [Abstract][Full Text] [Related]
5. Steady state concentrations of clomipramine and its major metabolite desmethylclomipramine in rat brain and serum after oral administration of clomipramine.
Weigmann H; Härtter S; Bagli M; Hiemke C
Eur Neuropsychopharmacol; 2000 Sep; 10(5):401-5. PubMed ID: 10974613
[TBL] [Abstract][Full Text] [Related]
6. NET occupancy by clomipramine and its active metabolite, desmethylclomipramine, in non-human primates in vivo.
Takano A; Nag S; Gulyás B; Halldin C; Farde L
Psychopharmacology (Berl); 2011 Jul; 216(2):279-86. PubMed ID: 21336575
[TBL] [Abstract][Full Text] [Related]
7. Effects of physiological covariables on pharmacokinetic parameters of clomipramine in a large population of cats after a single oral administration.
Lainesse C; Frank D; Beaudry F; Doucet M
J Vet Pharmacol Ther; 2007 Apr; 30(2):116-26. PubMed ID: 17348896
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of clomipramine during pregnancy.
Ter Horst PG; Proost JH; Smit JP; Vries MT; de Jong-van de Berg LT; Wilffert B
Eur J Clin Pharmacol; 2015 Dec; 71(12):1493-500. PubMed ID: 26416100
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of clomipramine and desmethylclomipramine after single-dose intravenous and oral administrations in cats.
Lainesse C; Frank D; Meucci V; Intorre L; Soldani G; Doucet M
J Vet Pharmacol Ther; 2006 Aug; 29(4):271-8. PubMed ID: 16846464
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
[TBL] [Abstract][Full Text] [Related]
11. Clomipramine demethylation rate is important on the outcome of obsessive-compulsive disorder treatment.
Marcourakis T; Bernik MA; Lotufo Neto F; Gedanke Shavitt R; Gorenstein C
Int Clin Psychopharmacol; 2015 Jan; 30(1):43-8. PubMed ID: 25279584
[TBL] [Abstract][Full Text] [Related]
12. Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography.
Westenberg HG; Drenth BF; de Zeeuw RA; de Cuyper H; van Praag HM; Korf J
J Chromatogr; 1977 Nov; 142():725-33. PubMed ID: 914945
[TBL] [Abstract][Full Text] [Related]
13. Clomipramine dose-effect study in patients with depression: clinical end points and pharmacokinetics. Danish University Antidepressant Group (DUAG).
Clin Pharmacol Ther; 1999 Aug; 66(2):152-65. PubMed ID: 10460069
[TBL] [Abstract][Full Text] [Related]
14. Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
Nielsen KK; Brøsen K; Gram LF
Eur J Clin Pharmacol; 1992; 43(4):405-11. PubMed ID: 1451721
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of clomipramine and desmethylclomipramine and clinical improvement in panic disorder.
Marcourakis T; Gorenstein C; Ramos RT; da Motta Singer J
J Psychopharmacol; 1999; 13(1):40-4. PubMed ID: 10221358
[TBL] [Abstract][Full Text] [Related]
16. Increased bioavailability of clomipramine after sublingual administration in rats.
Yoo SD; Yoon BM; Lee HS; Lee KC
J Pharm Sci; 1999 Nov; 88(11):1119-21. PubMed ID: 10564058
[TBL] [Abstract][Full Text] [Related]
17. Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography.
Westenberg HG; De Zeeuw RA; De Cuyper H; Van Praag HM; Korf J
Postgrad Med J; 1977; 53 Suppl 4():124-30. PubMed ID: 600889
[No Abstract] [Full Text] [Related]
18. The demethylation of imipramine and clomipramine as apparent from their plasma kinetics.
Nagy A; Johansson R
Psychopharmacology (Berl); 1977 Oct; 54(2):125-31. PubMed ID: 412206
[TBL] [Abstract][Full Text] [Related]
19. Comparative oxidative metabolic profiles of clomipramine in cats, rats and dogs: preliminary results from an in vitro study.
Lainesse C; Frank D; Beaudry F; Doucet M
J Vet Pharmacol Ther; 2007 Oct; 30(5):387-93. PubMed ID: 17803729
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of clomipramine, desmethylclomipramine, and hydroxylated metabolites in patients with depression receiving chronic treatment: model evaluation.
Gex-Fabry M; Haffen E; Paintaud G; Bizouard P; Sechter D; Bechtel PR; Balant LP
Ther Drug Monit; 2000 Dec; 22(6):701-11. PubMed ID: 11128238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
